Hancock, A A <br/><br/>
Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Mar 1995 
 - 1160-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Uptake Inhibitors--pharmacology<br/>Adrenergic alpha-2 Receptor Antagonists<br/>Animals<br/>Antidepressive Agents--pharmacology<br/>Behavior, Animal--drug effects<br/>Blood Pressure--drug effects<br/>Clonidine--pharmacology<br/>Guinea Pigs<br/>Heart Rate--drug effects<br/>Hippocampus--metabolism<br/>In Vitro Techniques<br/>Male<br/>Motor Activity--drug effects<br/>Mydriasis--chemically induced<br/>Neurons--metabolism<br/>Olfactory Bulb--physiology<br/>Pyrrolidines--pharmacology<br/>Rabbits<br/>Radioligand Assay<br/>Rats<br/>Rats, Sprague-Dawley<br/>Synaptosomes--metabolism<br/>Tyramine--analogs & derivatives